New hope for Alzheimer's patients: major drug trial seeks to slow memory loss
Disease control
Recruiting now
This study is testing whether an investigational drug called DMB-I can help improve thinking and memory in people with mild to moderate Alzheimer's disease. Researchers will enroll 450 adults aged 60-90 and randomly assign them to receive either DMB-I, a placebo (inactive pill), …
Phase: PHASE3 • Sponsor: Bigespas LTD • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC